Andrew Hessel.JPG

Andrew hessel

Andrew Hessel is the founder of Humane Genomics Inc., an early stage, open source biotechnology company specializing in designer synthetic viruses. The first application being developed is personalized cancer therapies for dogs. Hessel is also the co-founder of the Genome Project-write (GP-write), the international scientific effort advancing the design, construction, and testing of large genomes, including the human genome. He is based in San Francisco, California.